Sena Bio completes hundreds of millions of dollars in C-round financing
-
Last Update: 2021-03-08
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
June 11, China's high-volume gene sequencer platform manufacturer Sena Biotech (Beijing) Co., Ltd. announced the completion of round C financing. Following the acquisition of 50 million yuan of A-round investment in 2015, 130 million yuan of B-round investment in 2017 and B-round investment in 2018, Xena Bio received another round of hundreds of millions of dollars in financing.The financing was led by Guangzhou High-tech Zone Technology Holdings Group Co., Ltd., a technology strategic holding platform of Guangzhou Development Zone Financial Holdings Group Co., Ltd., and was used by Jinlu Capital to build the company's industrialization base, research and development center and sales headquarters in Guangzhou High-tech Zone to sequencing the scientific and technological achievements of its genes.According to the company's official website, Sena Biotech (Beijing) Co., Ltd. was founded in 2015, is a professional engaged in gene sequencing platform research and development and industrialization, committed to precision medicine high-precision technology development and life science cutting-edge research of high-tech companies. (Medical Valley original text has been reduced)
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
